Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters
- PMID: 8099862
- DOI: 10.2165/00003088-199324060-00006
Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters
Abstract
The effect of early blood sampling on the description of the vecuronium pharmacokinetic-pharmacodynamic relationship was studied following a bolus injection. Sample collection every 10 sec during the first 2 min showed a high concentration peak at 30 to 40 sec, accounting for an important proportion of the total area under the plasma concentration-time curve (AUC). Neglecting it, using only blood samples drawn at 1 and 2 min (limited sampling), led to a significant overestimation of noncompartmentally derived values of mean residence time, clearance, volume of distribution at steady-state and rate of transfer of vecuronium into the effect compartment. Compartmental pharmacokinetics could not be applied to concentration-time curves constructed with early samples, but limited sampling data were fitted to a 2-compartment model. Derived compartmental pharmacokinetic and pharmacokinetic-pharmacodynamic parameters were similar to those obtained noncompartmentally with complete sampling every 10 sec, because back-extrapolation to time zero contributed to the increase in the AUC. However, compartmental analysis does not provide an accurate description of concentration changes following injection.
Similar articles
-
Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients.Anesthesiology. 1996 Feb;84(2):330-9. doi: 10.1097/00000542-199602000-00010. Anesthesiology. 1996. PMID: 8602663 Clinical Trial.
-
The pharmacokinetics of vecuronium in male and female patients.Anesth Analg. 1998 Jun;86(6):1322-7. doi: 10.1097/00000539-199806000-00036. Anesth Analg. 1998. PMID: 9620528
-
Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis.Anesthesiology. 1988 May;68(5):771-6. doi: 10.1097/00000542-198805000-00016. Anesthesiology. 1988. PMID: 2897176
-
Neuromuscular block by vecuronium: simulation with a flow-volume model.Eur J Anaesthesiol. 1994 Mar;11(2):65-74. Eur J Anaesthesiol. 1994. PMID: 7909750
-
A semi-compartmental model describing the pharmacokinetic-pharmacodynamic relationship.Anesth Pain Med (Seoul). 2020 Jan 31;15(1):1-7. doi: 10.17085/apm.2020.15.1.1. Anesth Pain Med (Seoul). 2020. PMID: 33329783 Free PMC article. Review.
Cited by
-
Simulation of the kinetics of neuromuscular block: implications for speed of onset.Anesth Analg. 2013 Oct;117(4):792-802. doi: 10.1213/ANE.0b013e31827ee17f. Epub 2013 Mar 1. Anesth Analg. 2013. PMID: 23456666 Free PMC article.
-
Determination of the distribution volume that can be used to calculate the intravenous loading dose.Clin Pharmacokinet. 1998 Jul;35(1):1-7. doi: 10.2165/00003088-199835010-00001. Clin Pharmacokinet. 1998. PMID: 9673831
-
Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.Can J Anaesth. 1994 Oct;41(10):908-12. doi: 10.1007/BF03010933. Can J Anaesth. 1994. PMID: 8001209
-
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.J Pharmacokinet Biopharm. 1996 Feb;24(1):45-77. doi: 10.1007/BF02353510. J Pharmacokinet Biopharm. 1996. PMID: 8827583
-
Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling?J Pharmacokinet Biopharm. 1999 Apr;27(2):173-90. doi: 10.1023/a:1020653922866. J Pharmacokinet Biopharm. 1999. PMID: 10567954
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources